Bay Area Biotechs Poised to Win '07 VC Honors, But Living Costs Unnerve New Blood | GenomeWeb
NEW YORK (GenomeWeb News) — Bay Area life-science companies this year are poised to collect the lion’s share of the nation’s biotech venture capital, an Ernst & Young biotech observer told an industry conference held in the region last week.
 
Yet despite these gains, a shortage of entry-level workers, fed by the region’s sky-high housing costs, could affect future growth.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.